These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 25609198)
1. The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein. McConnell EJ; Devapatla B; Yaddanapudi K; Davis KR Oncotarget; 2015 Mar; 6(7):4649-62. PubMed ID: 25609198 [TBL] [Abstract][Full Text] [Related]
2. Lunasin sensitivity in non-small cell lung cancer cells is linked to suppression of integrin signaling and changes in histone acetylation. Inaba J; McConnell EJ; Davis KR Int J Mol Sci; 2014 Dec; 15(12):23705-24. PubMed ID: 25530619 [TBL] [Abstract][Full Text] [Related]
3. NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo. Cao MY; Lee Y; Feng NP; Al-Qawasmeh RA; Viau S; Gu XP; Lau L; Jin H; Wang M; Vassilakos A; Wright JA; Young AH J Pharmacol Exp Ther; 2004 Feb; 308(2):538-46. PubMed ID: 14610220 [TBL] [Abstract][Full Text] [Related]
4. Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways. Du Y; Gong J; Tian X; Yan X; Guo T; Huang M; Zhang B; Hu X; Liu H; Wang Y; Li J; Li M Tumour Biol; 2015 Sep; 36(10):7473-82. PubMed ID: 25908173 [TBL] [Abstract][Full Text] [Related]
5. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Johnson FM; Saigal B; Talpaz M; Donato NJ Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784 [TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449 [TBL] [Abstract][Full Text] [Related]
7. 3-Oxoolean-12-en-27-oic acid inhibits the proliferation of non-small cell lung carcinoma cells by inducing cell-cycle arrest at G0/G1 phase. Tae N; Seo J; Min BS; Ryoo S; Lee JH Anticancer Res; 2011 Jun; 31(6):2179-85. PubMed ID: 21737638 [TBL] [Abstract][Full Text] [Related]
8. Panaxydol Derived from Panax ginseng Inhibits G Lee JH; Leem DG; Chung KS; Kim KT; Choi SY; Lee KT Biol Pharm Bull; 2018; 41(11):1701-1707. PubMed ID: 30381670 [TBL] [Abstract][Full Text] [Related]
9. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604 [TBL] [Abstract][Full Text] [Related]
10. Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer. Thangavel C; Boopathi E; Liu Y; McNair C; Haber A; Perepelyuk M; Bhardwaj A; Addya S; Ertel A; Shoyele S; Birbe R; Salvino JM; Dicker AP; Knudsen KE; Den RB Clin Cancer Res; 2018 Mar; 24(6):1402-1414. PubMed ID: 29311118 [No Abstract] [Full Text] [Related]
12. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085 [TBL] [Abstract][Full Text] [Related]
13. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model. Tang FY; Chiang EP; Pai MH J Agric Food Chem; 2010 Oct; 58(20):11156-64. PubMed ID: 20866043 [TBL] [Abstract][Full Text] [Related]
14. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; BarĂ³n AE; Zeng C; Johnson TK; Bunn PA Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870 [TBL] [Abstract][Full Text] [Related]
15. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
16. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer. Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244 [TBL] [Abstract][Full Text] [Related]
17. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334 [TBL] [Abstract][Full Text] [Related]
18. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
19. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290 [TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mateen S; Tyagi A; Agarwal C; Singh RP; Agarwal R Mol Carcinog; 2010 Mar; 49(3):247-58. PubMed ID: 19908243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]